Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record of innovation in its key markets, and we anticipate the pattern will continue, allowing the wide-moat company to earn attractive economic profits.
Stryker made the most of its three-year head start in placing its Mako robots in hospitals, leaving Zimmer Biomet and Johnson & Johnson to play catch-up.
Zimmer Biomet's progress with its Rosa robot could put a crimp in Stryker's robust growth in knees on its Mako robot.
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.57 | 13.73 | 23.82 |
Price/Book Value | 4.36 | 2.17 | 7.33 |
Price/Sales | 4.08 | 1.82 | 6.44 |
Price/Cash Flow | 18.68 | 9.34 | 22.07 |
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Quick Ratio | 1.08 | 1.11 | 0.73 |
Current Ratio | 2.16 | 2.14 | 1.09 |
Interest Coverage | — | 5.42 | 25.00 |
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Return on Assets (Normalized) | 11.44% | 8.51% | 13.42% |
Return on Equity (Normalized) | 23.97% | 17.09% | 32.69% |
Return on Invested Capital (Normalized) | 14.10% | 11.66% | 20.33% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|$TW>KG | LOCK|mShK? | $167B | |||
| Medtronic PLC
MDT
| LOCK|g?rwK@ | LOCK|&@hd | $111B | |||
| Boston Scientific Corp
BSX
| LOCK|^@<@j& | LOCK|%YJV! | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|x$x<PZ!> | LOCK|wX@? | $49B | |||
| DexCom Inc
DXCM
| LOCK|RpS#kDY | LOCK|HJ!R | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$^q$rKJ | LOCK|G$ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|#b | LOCK|G%% | $23B | |||
| Steris PLC
STE
| LOCK|&vKLD& | LOCK|>TR$D | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|@Chh#Ht | LOCK|@& | $17B |
United States